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Abstract  
Background. Previous studies have found that TRPV1 and TRPA1 receptor agonists improve 
swallow response in patients with oropharyngeal dysphagia, but little is known about the 
expression of these receptors in the human oropharynx. The aim of this study was to assess 
the expression and localization of TRPV1 and TRPA1 in human samples from the oropharynx 
of healthy patients, to provide the basis for new pharmacological treatments for 
oropharyngeal dysphagia (OD). 
Methods. Samples from oropharyngeal regions innervated by cranial nerves V, IX and X 
(tongue, pharynx and epiglottis) were obtained during ENT surgery and processed either for 
mRNA (21 patients) or for immunohistochemical assays (7 patients). The expression analysis 
was performed with RT-qPCR using ACTBh as reference gene. H&E staining was used to 
study the histology; the immunohistochemical assay used a) neuron-specific enolase to detect 
nerve fibers or b) fluorescent probes to locate TRPV1 and TRPA1. 
Results. TRPV1 was expressed in the three studied regions, with higher levels in CN V 
region (tongue) than in CN X region (epiglottis) (p<0.05), and was localized at epithelial cells 
and nociceptive fibers in all studied regions. TRPA1 was also expressed in all studied regions 
but was always localized below the basal lamina. No immunoreactivity for TRPA1 was found 
on epithelial cells. 
Conclusions. TRPV1 and TRPA1 are widely expressed in the human oropharynx with two 
distinct patterns. Our study further confirms that TRPV1/A1 receptors are promising 
therapeutic targets to develop active treatments for OD patients. 
 
 
Keywords: Ankyrin-like with transmembrane domains protein 1, oropharyngeal dysphagia, 
sensory input, vanilloid receptor 1. 
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Key messages:  
- Previous studies have provided supportive evidence to suggest that TRPV1 and TRPA1 
agonists improve swallow response on neurogenic OD patients, but little is known about the 
expression and localization of these receptors in the oropharynx. 
- This study explores the expression and localization of TRPV1 and TRPA1 in human 
oropharyngeal samples with RT-qPCR and fluorescent immunohistochemistry. 
- TRPV1 and TPRA1 expression is found throughout the oropharynx and these receptors are 
immunolocalized with two specific patterns. TRPV1 is found on epithelial cells and 
submucosal sensory nerves while TRPA1 is only found below the basal lamina. 
- Oropharyngeal TRPV1/A1 receptors are promising therapeutic targets to develop active 
treatments for OD patients. 
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Introduction.  
 
Oropharyngeal dysphagia (OD) is a geriatric syndrome affecting 23% of independently-living 
and up to 51% of institutionalized older people (1,2,3). OD causes two groups of clinically 
relevant complications: decreased efficacy of swallowing that can lead to malnutrition and 
dehydration, and decreased safety of deglutition that can involve bolus penetration into the 
laryngeal vestibule and, in the most severe cases, tracheobronchial aspiration, leading to 
aspiration pneumonia (4,5). OD is also a highly frequent post-stroke complaint with an 
incidence of over 40% (6,7) and is a common condition in patients with neurodegenerative 
diseases such as Parkinson’s and Alzheimer’s disease, with reported prevalence of 35%-82% 
and 19%-84% respectively (8,9). There is no pharmacological treatment for OD yet and its 
management is mainly based on compensatory strategies such as food and liquid bolus 
adaptation, postures, and swallow maneuvers (10,11).  
Old and neurogenic patients with OD present decreased sensitivity in the oropharynx (12,13). 
Afferent myelinated nerve fibers in the superior laryngeal nerve have been observed to 
decrease with age and may be the cause of age-related sensory dysfunction of the oropharynx 
(14,15). In stroke patients, lack of sensitivity could be caused by interference in the 
connection between the sensory afferents and the cortex and the brainstem (16) as well as the 
disruption of afferent information processing at the cortex due to cortical lesion. These 
sensory deficits may lead to delayed swallowing response (4) and predispose to aspiration and 
aspiration pneumonia (17).  
It has been hypothesized that increasing the sensory input in these patients could modulate the 
cortical swallowing motor pathway and thus improve the swallowing response (18,19). This 
hypothesis led us to perform clinical assays to test capsaicinoids (TRPV1 agonist) and 
piperine (TRPV1/A1 agonist) as a pharmacological approach to treat OD, with the results that 
swallow safety and efficacy were significantly increased by improved oropharyngeal motor 
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response (20,21). However, more knowledge is needed about the mechanisms by which this 
approach works.  
Caterina et al identified the transient receptor potential cation channel, subfamily V, member 
1 (TRPV1) as the vanilloid receptor (22) and, since then, TRPV1 expression has been found 
in several human tissues; in neuronal tissues such as the dorsal root ganglia (23) and the 
trigeminal ganglia (24), and also in epithelial cells like bladder epithelial cells in the human 
urothelium (25) and keratinocytes of human epidermis (26). Following TRPV1 identification, 
several polymodal receptors have been identified. Among them, Story et al identified the 
transient receptor potential cation channel, subfamily A, member 1 (TRPA1) as a cold 
activated receptor (27). TRPA1 is also activated by piperine and low concentrations of 
menthol (28,29). However, little is known about the expression and localization of TRPV1 
and TRPA1 within the human oropharynx. 
The aim of this study was to explore the expression and localization of TRPV1 and TRPA1 in 
areas of the human oropharynx, including those innervated by trigeminal (cranial nerve V), 
glossopharyngeal (cranial nerve IX) and vagus (cranial nerve X) nerves. This knowledge may 
provide the basis to develop specific pharmacologic strategies with TRPV1 and TRPA1 
agonists to treat patients with OD. 
 
Patients, materials and methods 
 
Sample collection. Human biopsies were obtained during routine major ENT surgical 
interventions once patients had granted informed consent. The samples were innervated by 
cranial nerves V (tongue), IX (faucial pillars and pharynx) and X (pharynx and epiglottis) 
with an average size of 8 mm x 8 mm x 4 mm for histological procedures and 3 mm x 3 mm x 
3 mm for molecular biology procedures. The patients had head and neck cancer located at oral 
cavity (21.4%), pharynx (17.9%) or larynx (53.6%), more than half of them at early stage 
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(53.8% T1N0M0), or had undergone tonsillectomy for benign disease (7.1%) and had not 
received chemo- or radiotherapy previous to the surgical intervention; all tissues used in the 
study were examined to confirm they were free from pathology. Samples from 7 patients 
(mean age 52.6±16.0, 85.7% males) were processed to study both the histology and the 
innervation of the oropharynx and to localize TRPV1 and TRPA1 within tissues by 
immunohistochemistry. Samples from 21 patients (mean age 63.7±11.4, 85.7% males) were 
processed to quantify TRPV1 and TRPA1 expression through RT-qPCR, 
Tissue collection and storage were performed according to the recommendations from the 
“Human Tissue Act” of 21 October 2002 in the HHW Department of USA and obeying the 
current Spanish law about the use and storage of human tissue (Ley 14/2007 Título V 
Capítulo III). The Ethical Committee of the Consorci Sanitari del Maresme approved the 
study under the code 22/09.  
Histological sample preparation. Samples destined to immunohistochemistry were collected 
in paraformaldehyde 5% and incubated at 4ºC for 1 to 2 hours. Biopsies were then cut in half, 
one part for colorimetric and the other for fluorescent immunohistochemistry procedures. The 
colorimetric immunohistochemistry samples were processed with the routine protocol of 
infiltration using the Tissue-Tek VIP Vacuum Infiltration Processor and reactives (Sakura 
Finetek, Tokyo, Japan) and then oriented by a pathologist and embedded in paraffin blocks. 
The samples were cut in 4µm slices at room temperature and processed. For fluorescent 
immunohistochemistry, samples were washed with phosphate buffer saline and incubated in 
cryoprotective solution (20% sucrose in phosphate buffer 0.1M) at 4ºC O/N, then frozen in 
Optimal Cutting Temperature compound (Sakura Finetek, Tokyo, Japan) and stored at -80ºC 
until used. The samples were cut in 6-10µm slices at -20ºC in a cryostat, set in FLEX IHC 
microscope slides (Dako, Glostrup, Denmark) and stored at -20ºC until used (30). 
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Colorimetric immunohistochemistry. Histological preparations were dyed with 1) 
hematoxylin eosin to examine the structure of oropharyngeal mucosa and submucosa using 
the Leica ST4020 device and reactives (Leica Biosystems, Nussloch, Germany) or 2) with 
colorimetric immunohistochemistry with the anti-Neuron-Specific Enolase antibody to find 
the location of nerve fibers using the AutostainerLink 48 (Dako, Glostrup, Denmark). 
Histological preparations were observed under a Nikon Eclipse E600 optical microscope 
(Nikon, Tokyo, Japan) and microscopic photographs were taken with an Olympus DP20 
digital camera (Olympus, Tokyo, Japan). 
Fluorescent immunohistochemistry. To locate TRP receptors, histological preparations 
were fixed with paraformaldehyde 4% in Hank’s Balanced Salt Solution (HBSS) 0.1M, 
permeated with Triton 0.5%, blocked with HBSS-goat serum 10%, incubated with 1:500 
dilution of anti-TRPV1 or anti-TRPA1 goat antibody (Alomone Labs, Jerusalem, Israel) 
diluted in HBSS-goat serum 10% at 4ºC O/N. They were washed and then incubated with Rb-
A568 (Thermo Fisher Scientific Inc., Carlsbad, USA) as secondary antibody diluted in HBSS-
Goat serum 10% at 37ºC for 1 hour. Finally, preparations were incubated with Hoechst 
(Thermo Fisher Scientific Inc., Carlsbad, USA) and mounted with Fluoprep (BioMérieux, 
Rhône-Alpes, France). Histological preparations were observed and recorded with a Leica’s 
laser confocal microscope SP5 (Leica Microsystems, Wetzlar, Germany) with 40x or 20x 
objectives. Three controls were performed for each antibody in each studied region: one using 
the antigenic peptide provided by the manufacturer at saturating concentration as blocking 
control, another without the primary antibody to check for unspecific binding of the 
secondary antibody and the last one without antibodies to check for tissue autofluorescence. 
mRNA extraction. Samples intended for molecular biology were collected in RNAlater® 
solution (Thermo Fisher Scientific Inc., Carlsbad, USA), incubated O/N at 4ºC and stored at - 
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20ºC until used. mRNA was extracted using TRIzol® (Thermo Fisher Scientific Inc., 
Carlsbad, USA) protocol, its purity and concentration was assessed with spectrophotometer 
and it was stored in DEPC-treated water (Thermo Fisher Scientific Inc., Carlsbad, USA) at -
20ºC until used. 
Retrotranscription and RT-qPCR. Samples were treated with DNase I recombinant, 
RNase-free (Roche, Basel, Switzerland) to eliminate all traces of genomic DNA. mRNA was 
retrotranscribed using Transcriptor First Strand cDNA Synthesis Kit (Roche, Basel, 
Switzerland) to obtain cDNA. RT-qPCR was performed with a Roche’s LightCycler® 2.0 
using LighCycler® TaqMan® Master kit (Roche, Basel, Switzerland). The PCR programs 
consisted of a 10-minute, 95ºC pre-incubation phase followed by 30 to 60 amplification 
cycles with an annealing temperature of 64º. The expression of human β-actin (ACTBh) as 
reference gene and TRPV1 and TRPA1 as target genes were analyzed by this method. All 
primers (Table 1) were designed through the Universal Probe Library software (Roche, Basel, 
Switzerland). 
 Data analysis. TRPV1 and TRPA1 patterns of localization were analyzed using the mean 
intensity of signal of two consecutive 10x10 µm ROIs containing 700 pixels each. These 
mean intensities were graphed relative to the distance between the most superficial side of the 
ROIs and the basal lamina. The standard error was calculated for each of these means. 
TRPV1 and TRPA1 relative expressions to ACTBh were obtained using standard curves of 
the target and reference genes. The relative expression of all regions was compared using 
Kruskal-Wallis test  and then Mann-Whitney U test was used to confirm differences between 
pairs; p<0.05 was considered as statistically significant. Results are expressed as the mean 
relative expression±standard error of the mean. Statistical analysis was performed with 
GraphPad Prism 5.0 (GraphPad Software Inc, San Diego, USA). 
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Results 
 
Colorimetric histology 
1) Histology and innervation of the oropharynx 
Tongue mucosa had the characteristics of masticatory mucosa, with para-keratinized 
epithelium covering the filiform papillae (Fig 1A). Pharynx (Fig 1C) and epiglottis (Fig 1E) 
mucosa had the aspect of lining mucosa, with non-keratinized epithelia at the outer layers of 
mucosa. The basal lamina was identified between the epithelium and the submucosa in all 
regions. All regions showed abundant innervation consisting in thick fiber bundles at deep 
areas of the submucosa and single fibers approaching the epithelium, some of them reaching 
the basal lamina in tongue (Fig 1B) and lingual surface of epiglottis (Fig 1F). However, no 
nerve fibers were seen above the basal lamina in any sample of the studied regions. 
Fluorescent immunohistochemistry 
2) TRPV1 localization.  
TRPV1 immunofluorescence was localized on the plasma membrane of the epithelial cells in 
all studied areas, showing a stronger signal in epithelial cells of the basal and intermediate 
layers and weaker signal on epithelial cells of more superficial and mature layers of the 
epithelium (Fig 2). TRPV1 was also found in nociceptive Aδ fibers and polymorphonuclear 
leukocytes in the submucosa near the basal lamina (Fig 2C). The primary antibody control 
with specific blocking peptide showed no signal, suggesting that the immunoreactivity found 
is specific for TRPV1 (data not shown). 
3) TRPA1 localization 
TRPA1 was found below the basal lamina in all regions, on cells that morphologically 
resembled submucosal fibroblasts. No signal was found on epithelial cells (Fig 3). Specificity 
control of the primary antibody with blocking peptide showed no signal, suggesting that the 
immunoreactivity was specific for TRPA1 (data not shown). 
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4) TRPV1/A1 localization patterns 
TRPV1 and TRPA1 showed two distinct patterns of localization in the three areas (CN V, IX, 
X) of the human oropharynx: TRPV1 was localized in the epithelium with greater intensity 
near the basal lamina and gradually decreasing towards the superficial layers of the 
epithelium, and in nerve fibers of the submucosa. In contrast, TRPA1 was only localized in 
sparse cells and submucosal structures below the basal lamina; the morphology of 
immunoreactive cells resembled that of fibroblasts (Fig 4). 
RT-qPCR 
5) Quantitative mRNA TRPV1 analysis.  
The relative expression of TRPV1 to β-actin was 25.43·10
-5
±2.117·10
-5
 in the region 
innervated by CN V (tongue), 20.97·10
-5
±2.056·10
-5
 in the region innervated by CN IX and X 
(faucial pillars and pharynx) and 16.59·10
-5
±1.494·10
-5
 in the region innervated by CN X 
(lingual surface of epiglottis), showing a significantly higher relative expression of TRPV1 to 
β-actin in tongue than in epiglottis (p<0.05) (Fig 5A).  
6) Quantitative mRNA TRPA1 analysis 
The relative expression of TRPA1 to β-actin was 2.736·10
-5
±7.805·10
-6
 in the region 
innervated by CN V (tongue), 1.493·10
-5
±2.684·10
-6
 in th  region innervated by CN IX 
(faucial pillars) and 2.432·10
-5
±7.970·10
-6
 in the region innervated by CN X (lingual surface 
of epiglottis), without significant differences between these areas (Fig 5A).  
TRPA1 relative expression was significantly lower than TRPV1 relative expression in all the 
studied areas (p<0.001) (Fig 5A). The relative expression of TRPV1 to TRPA1 was 
38.44±13.11 in the region innervated by CN V (tongue), 16.71±3.24 in the region innervated 
by CN IX (faucial pillars) and 27.14±9.52 in the region innervated by CN X (lingual surface 
of epiglottis), showing higher expression of TRPV1 in a consistent proportion in all areas (Fig 
5B). Nevertheless, it should be noted that the biopsies contained proportionally more 
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epithelial cells expressing TRPV1 than subepithelial elements expressing TRPA1, which 
could affect the comparative assessment. 
Discussion 
 
Our results show that TRPV1 and TRPA1 channels are expressed throughout the regions 
innervated by the cranial nerves V, IX and X and are localized in two distinct patterns: 
TRPV1 is localized in epithelial cells and a few sensory fibers in the oropharyngeal 
submucosa while TRPA1 is localized below the basal lamina but not in epithelial cells from 
the oropharynx. 
  
The cranial nerves V, IX and X provide oropharyngeal chemosensation through free endings 
of their axons. Signals elicited by stimuli travel along these axons to the cell bodies located in 
the corresponding ganglia and then continue to the spinal nucleus of the trigeminal complex 
of the brainstem (31). 
  
Our results show how the oropharyngeal nerve fibers travel in bundles in deep layers of the 
submucosa while single axons reach the basal lamina and even contact the epithelial cells of 
the basal layer of the epithelium. However, no fibers were observed in the epithelium beyond 
the basal lamina. The presence of free nerve endings in the epithelium has been debated in the 
literature. Some studies have shown the presence of free nerve endings in contact with the 
basal lamina (32) and even penetrating it to reach superficial layers of the epithelium (33). 
The nerve endings found in our study might be the ones responding to chemical, thermal and 
noxious stimuli in the oropharynx. 
 
Our results show the presence of TRPV1 on the epithelial cells of tongue, pharynx and 
epiglottis as well as in Aδ fibers of the submucosa and TRPV1 expression in the regions 
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innervated by the cranial nerves V, IX and X. Furthermore, the results show decreasing 
expression of TRPV1 the lower the studied region, with significantly different levels of 
expression between tongue and epiglottis.  
TRPV1 expression has been thoroughly examined in murine models, providing evidence of 
its presence both at the epithelial cells and in afferent fibers throughout the oropharynx 
(34,35,36). However, there is less information on TRPV1 expression and localization in the 
human oropharynx. Hou et al found TRPV1 expression and immunoreactivity in human 
trigeminal ganglia neuronal cells and co-localization with CGRP and SP (37). TRPV1 has 
been also localized in peripheral free nerve endings of the human larynx (38) and tongue (39). 
Some studies have also found the expression and localization of TRPV1 in epithelial cells 
from the tongue (39,40) where, as previously hypothesized, it could trigger the release of 
inflammatory mediators that would interact with neuronal terminals and so amplify the 
signaling (41). 
From a functional point of view, it can be hypothesized that TRPV1 agonists, such as 
capsaicin, elicit their effect at both epithelial cells of the basal layer and afferent fibers in the 
submucosa. Capsaicin is a lipophilic molecule which permeates epithelial layers (42,43) and 
so can travel through the epithelium and bind TRPV1 expressed by epithelial cells. This then 
activates Ca
+2
 inward currents in those cells which in turn activate the biosynthesis of 
endocannabinoids or other molecules known to modulate TRPV1 (44,45) and are synthesized 
in the epithelium (46); these endogenous agonists, along with the exogenous TRPV1 agonists, 
activate TRPV1 on the nerve fibers. Localized effect of capsaicin is thus amplified by the 
epithelium to elicit its pungent sensation through the afferent fibers of the submucosa. 
Regarding TRPA1, our results show TRPA1 immunoreactivity on the surface of cells, 
presumably fibroblasts, below the basal lamina in all studied regions but not in epithelial 
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cells. We found that TRPA1 expression is similar in all the regions innervated by the cranial 
nerves V, IX and X, and at considerably lower levels than the relative expression of TRPV1.  
Bautista et al described that the population of trigeminal ganglia neurons expressing TRPA1 
represents 20% of small diameter axon neurons, all of which co-localized TRPA1 and TRPV1 
while most of them also co-localized CGRP. They suggested that TRPA1 activates a 
subpopulation of peptidergic sensory neurons which are sensitive to capsaicin and produce 
peptidic inflammatory mediators (47). As for peripheral localization of TRPA1, previous 
studies have also found evidence of the presence of TRPA1 on nerves in human tongue (48) 
and pharynx (49) as well as in epithelial cells and fibroblasts of human skin and bronchial 
epithelia (50,51). At these locations, it could be involved in inflammatory processes by 
stimulating the synthesis and release of cytokines such as IL-8 (50,51,52). 
As stated above, the lower TRPA1 expression relative to TRPV1 in the studied regions could 
be due to the fact that biopsies contain proportionally more epithelial cells expressing TRPV1 
than subepithelial elements expressing TRPA1; further research should be done to determine 
the difference of expression between TRPV1 and TRPA1 in peripheral tissues of the 
oropharynx. 
Several studies have pointed out that oropharyngeal sensitivity is reduced in older people due 
to a decrease in myelinated sensory fibers (12,14,15). This study has not checked the effect of 
age on the expression of TRPV1 and TRPA1, but considers it would be of great interest to 
assess the effect of age on expression in future research. 
In summary, the present study confirms the presence of TRPV1 and TRPA1 in the regions 
where capsaicinoids and piperine were thought to elicit their pharmacological effect by 
enhancing afferent sensory inputs to the cortex and swallowing centers (20,21). The study 
presents two distinct patterns for the localization of TRPV1 and TRPA1: TRPV1 is found 
within epithelial cells of the oropharynx while TRPA1 is found below the basal lamina. The 
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 14  
anatomical and histological map of TRPV1 and TRPA1 expression may help to explain the 
way TRPV1 and TRPA1 respond to stimuli from both capsaicinoids and piperine and set the 
basis for future use of both agonists to treat OD. These studies should also consider the 
possible chemical desensitization of these receptors after continuous long term exposure to 
high doses of the agonists. 
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Tables 
 
Antibody Description Dilution Secondary 
Anti-TRPV1 Rabbit polyclonal (Alomone Labs, 
Jerusalem, Israel) 
1:500 Rb-A568 (Thermo Fisher 
Scientific Inc., Carlsbad, USA) 
Anti-TRPA1 Rabbit polyclonal (Alomone Labs, 
Jerusalem, Israel) 
1:500 Rb-A568 (Thermo Fisher 
Scientific Inc., Carlsbad, USA) 
 
Table 1. Primary and secondary antibodies used for the fluorescent immunohistochemical 
assays. 
 
 
 
 
 
 
 
 
  
 
 
Table 1. Primers used for the RT-qPCR. TRP stands for transient receptor potential channel. 
UPL stands for Universal Probe Library. 
 
Gene UPL Primers 
β-actin (ACTBh) 64 Left: 5’ ccaaccgcgagaagatga 3’ 
Right: 5’ tccatcacgatgccagtg 3’ 
TRP subfamily V member 1 
(TRPV1) 
41 Left: 5’ cagctacagtgagatgcttttctt 3’ 
Right: 5’ atggaagccacatactccttg 3’ 
TRP subfamily A member 1 
(TRPA1) 
32 Left: 5’ tcaccatgagctagcagactattt 3’ 
Right: 5’ gagagcgtccttcagaatcg 3’ 
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Figure legends 
Figure 1. Hematoxylin and eosin stain (HE) (top) and Neuronal Specific Enolase (NSE) 
(bottom) histological preparations under optical microscope. A Mucosa and submucosa of the 
mid third of the tongue with para-keratinized epithelia over the filiform papillae. B Region 
near A; most nerve fibers travel below the epithelium (arrowheads) and some nerve fibers 
contact the epithelial cells of the basal layer (arrow). C and E Lining mucosa of the posterior 
wall of the pharynx and the lingual surface of the epiglottis with non-keratinized epithelia. D 
Region near C; a single nerve fiber runs below the basal lamina (arrowhead). F Region near 
E; single fibers and fiber bundles run below the basal lamina (arrowheads) and a sensory 
nerve structure contacts it (arrow). Top images were obtained under 100x and bars measure 
50µm; bottom images were obtained under 200x and bars measure 30µm. 
 
Figure 2. TRPV1 (red) immunoreactivity (IR) in fluorescent immunohistochemistry 
preparations with Hoechst staining of nuclei (blue) under confocal microscope. A Tongue 
mucosa and submucosa with TRPV1 IR on the membrane of epithelial cells from the basal 
layer of the epithelium; signal progressively fades in outer layers of the epithelium. B 
Pharynx mucosa and submucosa with intense TRPV1 IR on the membrane of epithelial cells 
from the basal layer of the epithelium; weaker TRPV1 IR is seen under the epithelium on 
blood vessel (asterisk) endothelial cells. C Epiglottis mucosa and submucosa with TRPV1 IR 
on the membrane of epithelial cells from the basal layer of the epithelium; TRPV1 IR can also 
be seen on polymorphonuclear leukocytes (arrowheads) and on a 4-5µm thick fiber-like 
structure resembling an Aδ nerve fiber (arrow). Images were obtained under 400x. Bars 
measure 30µm. 
 
Figure 3. TRPA1 (red) immunoreactivity (IR) in fluorescent immunohistochemistry 
preparations with Hoechst staining of nuclei (blue) under confocal microscope. A and B 
Tongue mucosa and submucosa with TRPA1 IR on subepithelial elements, both between the 
filiform papillae and deeper into the submucosa. C, D, E and F Pharynx (C and D) and 
epiglottis (E and F) mucosa and submucosa with TRPA1 IR on scattered subepithelial 
elements. No signal is found on epithelial cells in any of the images. Images were obtained 
under 200x (top) or 400x (bottom). Bars measure 100µm (top) or 30µm (bottom). 
 
Figure 4. TRPV1 and TRPA1 distribution pattern. A Schematic drawing of the distribution 
pattern of TRPV1 (red) and TRPA1 (green) in the oropharynx. Nerves and fibroblasts are 
depicted in the submucosa. B Fluorescence intensity for TRPV1 (red) and TRPA1 (green) 
relative to the distance from the basal lamina of the epithelium of the oropharyngeal mucosa. 
Values of the X axis correspond to the distance between the most superficial side of the ROI 
and the basal lamina. Positive values of the X axis correspond to positions above the basal 
lamina (epithelium) and negative values correspond to positions below the basal lamina 
(submucosa). Intensity values are given as the mean of two correlative 10x10 µm regions of 
interest (ROIs). The SEM of each bar is displayed. A straight line is drawn in the position 0 of 
the X axis corresponding to the basal lamina. 
 
Figure 5. TRPV1 and TRPA1 expression analysis. A Relative expression of TRPV1 (right) 
and TRPA1 (left) to β-actin (ACTBh) in the areas innervated by the trigeminal (CN V), 
glossopharyngeal (CN IX) and vagus (CN X) nerves. * p < 0.05. B Relative expression of 
TRPV1 to TRPA1 in the areas innervated by the trigeminal (CN V), glossopharyngeal (CN 
IX) and vagus (CN X) nerves. 
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Hematoxylin and eosin stain (HE) (top) and Neuronal Specific Enolase (NSE) (bottom) histological 
preparations under optical microscope. A Mucosa and submucosa of the mid third of the tongue with para-
keratinized epithelia over the filiform papillae. B Region near A; most nerve fibers travel below the 
epithelium (arrowheads) and some nerve fibers contact the epithelial cells of the basal layer (arrow). C and 
E Lining mucosa of the posterior wall of the pharynx and the lingual surface of the epiglottis with non-
keratinized epithelia. D Region near C; a single nerve fiber runs below the basal lamina (arrowhead). F 
Region near E; single fibers and fiber bundles run below the basal lamina (arrowheads) and a sensory nerve 
structure contacts it (arrow). Top images were obtained under 100x and bars measure 50µm; bottom 
images were obtained under 200x and bars measure 30µm.  
290x164mm (300 x 300 DPI)  
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TRPV1 (red) immunoreactivity (IR) in fluorescent immunohistochemistry preparations with Hoechst staining 
of nuclei (blue) under confocal microscope. A Tongue mucosa and submucosa with TRPV1 IR on the 
membrane of epithelial cells from the basal layer of the epithelium; signal progressively fades in outer layers 
of the epithelium. B Pharynx mucosa and submucosa with intense TRPV1 IR on the membrane of epithelial 
cells from the basal layer of the epithelium; weaker TRPV1 IR is seen under the epithelium on blood vessel 
(asterisk) endothelial cells. C Epiglottis mucosa and submucosa with TRPV1 IR on the membrane of 
epithelial cells from the basal layer of the epithelium; TRPV1 IR can also be seen on polymorphonuclear 
leukocytes (arrowheads) and on a 4-5µm thick fiber-like structure resembling an Aδ nerve fiber (arrow). 
Images were obtained under 400x. Bars measure 30µm.  
247x80mm (300 x 300 DPI)  
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TRPA1 (red) immunoreactivity (IR) in fluorescent immunohistochemistry preparations with Hoechst staining 
of nuclei (blue) under confocal microscope. A and B Tongue mucosa and submucosa with TRPA1 IR on 
subepithelial elements, both between the filiform papillae and deeper into the submucosa. C, D, E and F 
Pharynx (C and D) and epiglottis (E and F) mucosa and submucosa with TRPA1 IR on scattered subepithelial 
elements. No signal is found on epithelial cells in any of the images. Images were obtained under 200x (top) 
or 400x (bottom). Bars measure 100µm (top) or 30µm (bottom).  
274x180mm (300 x 300 DPI)  
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TRPV1 and TRPA1 distribution pattern. A Schematic drawing of the distribution pattern of TRPV1 (red) and 
TRPA1 (green) in the oropharynx. Nerves and fibroblasts are depicted in the submucosa. B Fluorescence 
intensity for TRPV1 (red) and TRPA1 (green) relative to the distance from the basal lamina of the epithelium 
of the oropharyngeal mucosa. Values of the X axis correspond to the distance between the most superficial 
side of the ROI and the basal lamina. Positive values of the X axis correspond to positions above the basal 
lamina (epithelium) and negative values correspond to positions below the basal lamina (submucosa). 
Intensity values are given as the mean of two correlative 10x10 µm regions of interest (ROIs). The SEM of 
each bar is displayed. A straight line is drawn in the position 0 of the X axis corresponding to the basal 
lamina.  
204x186mm (300 x 300 DPI)  
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Figure 5. TRPV1 and TRPA1 expression analysis. A Relative expression of TRPV1 (right) and TRPA1 (left) to 
β-actin (ACTBh) in the areas innervated by the trigeminal (CN V), glossopharyngeal (CN IX) and vagus (CN 
X) nerves. * p < 0.05. B Relative expression of TRPV1 to TRPA1 in the areas innervated by the trigeminal 
(CN V), glossopharyngeal (CN IX) and vagus (CN X) nerves.  
190x199mm (300 x 300 DPI)  
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